MonDec 16th, 2019
Lantern Pharma Expands and Strengthens Board of Directors with Healthcare and Pharma Industry Veterans Franklyn Prendergast, MD, Ph.D. and Vijay Chandru, Ph.D.
Lantern Pharma Press Release Lantern Pharma Expands and [...]
TueOct 29th, 2019
WedOct 2nd, 2019
Lantern Pharma and National Cancer Institute Partner to Aid Precision Oncology Research and Treatments
Lantern Press Release October 01, 2019 08:00 ETLantern [...]
WedSep 18th, 2019
Lantern Pharma CEO Panna Sharma to Showcase AI Platform at Drug Repositioning, Repurposing and Rescue Conference
Lantern Pharma Press Release Lantern Pharma CEO Panna [...]
WedSep 4th, 2019
Lantern Pharma Chief Scientific Officer Gregory Tobin to Speak at TMED 10: Disruptive Innovation in Healthcare Conference
Lantern Pharma Press Release Lantern Pharma Chief Scientific [...]
FriMar 29th, 2019
Lantern Pharma Announces Multiple Presentations at AACR 2019
Lantern Pharma Announces Multiple Presentations at AACR 2019 [...]
Let’s start a conversation about the future of cancer drug development.
We are a biotech pharma at the intersection of Artificial Intelligence, genomics, and oncology drug development.